Exosome-Derived microRNA: Potential Target for Diagnosis and Treatment of Sepsis

Exosome-derived microRNAs (miRNAs) are emerging as pivotal players in the pathophysiology of sepsis, representing a new frontier in both the diagnosis and treatment of this complex condition. Sepsis, a severe systemic response to infection, involves intricate immune and nonimmune mechanisms, where e...

Full description

Saved in:
Bibliographic Details
Main Authors: Yujie Xiao, Yixuan Yuan, Dahai Hu, Hongtao Wang
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2024/4481452
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550505687023616
author Yujie Xiao
Yixuan Yuan
Dahai Hu
Hongtao Wang
author_facet Yujie Xiao
Yixuan Yuan
Dahai Hu
Hongtao Wang
author_sort Yujie Xiao
collection DOAJ
description Exosome-derived microRNAs (miRNAs) are emerging as pivotal players in the pathophysiology of sepsis, representing a new frontier in both the diagnosis and treatment of this complex condition. Sepsis, a severe systemic response to infection, involves intricate immune and nonimmune mechanisms, where exosome-mediated communication can significantly influence disease progression and outcomes. During the progress of sepsis, the miRNA profile of exosomes undergoes notable alterations, is reflecting, and may affect the progression of the disease. This review comprehensively explores the biology of exosome-derived miRNAs, which originate from both immune cells (such as macrophages and dendritic cells) and nonimmune cells (such as endothelial and epithelial cells) and play a dynamic role in modulating pathways that affect the course of sepsis, including those related to inflammation, immune response, cell survival, and apoptosis. Taking into account these dynamic changes, we further discuss the potential of exosome-derived miRNAs as biomarkers for the early detection and prognosis of sepsis and advantages over traditional biomarkers due to their stability and specificity. Furthermore, this review evaluates exosome-based therapeutic miRNA delivery systems in sepsis, which may pave the way for targeted modulation of the septic response and personalized treatment options.
format Article
id doaj-art-9521b7cdd0804575b5e1542ec091130c
institution Kabale University
issn 2314-7156
language English
publishDate 2024-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-9521b7cdd0804575b5e1542ec091130c2025-02-03T06:06:37ZengWileyJournal of Immunology Research2314-71562024-01-01202410.1155/2024/4481452Exosome-Derived microRNA: Potential Target for Diagnosis and Treatment of SepsisYujie Xiao0Yixuan Yuan1Dahai Hu2Hongtao Wang3Department of Burns and Cutaneous SurgeryDepartment of Burns and Cutaneous SurgeryDepartment of Burns and Cutaneous SurgeryDepartment of Burns and Cutaneous SurgeryExosome-derived microRNAs (miRNAs) are emerging as pivotal players in the pathophysiology of sepsis, representing a new frontier in both the diagnosis and treatment of this complex condition. Sepsis, a severe systemic response to infection, involves intricate immune and nonimmune mechanisms, where exosome-mediated communication can significantly influence disease progression and outcomes. During the progress of sepsis, the miRNA profile of exosomes undergoes notable alterations, is reflecting, and may affect the progression of the disease. This review comprehensively explores the biology of exosome-derived miRNAs, which originate from both immune cells (such as macrophages and dendritic cells) and nonimmune cells (such as endothelial and epithelial cells) and play a dynamic role in modulating pathways that affect the course of sepsis, including those related to inflammation, immune response, cell survival, and apoptosis. Taking into account these dynamic changes, we further discuss the potential of exosome-derived miRNAs as biomarkers for the early detection and prognosis of sepsis and advantages over traditional biomarkers due to their stability and specificity. Furthermore, this review evaluates exosome-based therapeutic miRNA delivery systems in sepsis, which may pave the way for targeted modulation of the septic response and personalized treatment options.http://dx.doi.org/10.1155/2024/4481452
spellingShingle Yujie Xiao
Yixuan Yuan
Dahai Hu
Hongtao Wang
Exosome-Derived microRNA: Potential Target for Diagnosis and Treatment of Sepsis
Journal of Immunology Research
title Exosome-Derived microRNA: Potential Target for Diagnosis and Treatment of Sepsis
title_full Exosome-Derived microRNA: Potential Target for Diagnosis and Treatment of Sepsis
title_fullStr Exosome-Derived microRNA: Potential Target for Diagnosis and Treatment of Sepsis
title_full_unstemmed Exosome-Derived microRNA: Potential Target for Diagnosis and Treatment of Sepsis
title_short Exosome-Derived microRNA: Potential Target for Diagnosis and Treatment of Sepsis
title_sort exosome derived microrna potential target for diagnosis and treatment of sepsis
url http://dx.doi.org/10.1155/2024/4481452
work_keys_str_mv AT yujiexiao exosomederivedmicrornapotentialtargetfordiagnosisandtreatmentofsepsis
AT yixuanyuan exosomederivedmicrornapotentialtargetfordiagnosisandtreatmentofsepsis
AT dahaihu exosomederivedmicrornapotentialtargetfordiagnosisandtreatmentofsepsis
AT hongtaowang exosomederivedmicrornapotentialtargetfordiagnosisandtreatmentofsepsis